Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 1 of 718 for:    ABP 501
Previous Study | Return to List | Next Study

A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05073315
Recruitment Status : Recruiting
First Posted : October 11, 2021
Last Update Posted : January 13, 2022
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 26, 2023
Estimated Study Completion Date : October 26, 2023